Tirzepatide Cost in 2026: Every Payment Option Compared

Tirzepatide medicine as two brand names and is found at the compounding pharmacy at the nearby price. The difference between the lowest and the highest legal way exceeds $900 a month. Here we discuss different options of payments so that you can compare all costs, not only the pharmacy bill.

Tirzepatide Cost Overview: Brand Name vs Compounded

Mounjaro and Zepbound List Prices

Eli Lilly markets tirzepatide as Mounjaro (type 2 diabetes) and Zepbound (chronic weight management). The wholesale acquisition cost is $1,086 per month for Zepbound and $1,112 for Mounjaro (Eli Lilly investor relations, October 2026). Retail cash prices run $1,000 to $1,135 for Zepbound and $1,000 to $1,085 for Mounjaro. Both sit below Wegovy at $1,349 per month (NovoCare, October 2026) but remain out of reach for most self-pay patients.

Compounded Tirzepatide Pricing Tiers

Licensed 503A compounding pharmacies can legally produce tirzepatide formulations under a physician's prescription. Two providers currently serve most of the US market. BiltRx offers compounded tirzepatide at a flat $129 per month regardless of dose, with consultation and shipping fees added separately (biltrx.com, verified 22 Oct 2026). Arc-1 uses dose-based pricing: $199.99 at 2.5 mg, $249.99 at 5 mg and $399.99 at 7.5 mg, with free consultation and free expedited shipping included (arc-1.co, verified 22 Oct 2026). Arc-1 is not available in California, Arkansas, Indiana, Minnesota or South Carolina.

How to Compare Total Cost, Not Just the Sticker Price

Usually, a statement claiming the monthly amount advertised is different from what you will eventually pay. The presence of three types of hidden fees can convert a cost-effective alternative into an expensive one during the period of a complete course.

Consultation Fees

Both compounded suppliers need you to undergo a telehealth consultation. BiltRx assesses a consultation fee in addition to the base $129 fee. Arc-1 incorporates the consultation charge as part of its price to dispense medication. Also, for brand-name tirzepatide, there is a separate physician visit charge that ranges from $50 to $250, depending on your provider.

Shipping and Handling

The transport of Tirzepatide requires a cold chain process. BiltRx applies a charge to the delivery. Arc-1 offers fast delivery. LillyDirect incorporates delivery into its prices. There are no shipping expenses for retail pharmacies.

Dose Escalation Over Time

Tirzepatide treatment begins at 2.5 mg and escalates every four weeks through 5 mg, 7.5 mg, 10 mg and up to 15 mg. With flat-rate providers like BiltRx ($129/mo) or Mounjaro self-pay ($499/mo), escalation does not change your bill. With dose-tiered pricing like Arc-1 or Zepbound self-pay, your cost increases as your dose increases. A patient starting Arc-1 at $199.99 could be paying $399.99 within three months. That difference compounds over a year of treatment.

Provider Cost Comparison

The software has placed the product cards for BiltRx and Arc-1 here. Each of the cards contains current pricing along with applicable charges, state availability and our editorial rating. To view a comparison of these two compounded companies, see our BiltRx vs Arc-1 comparison.

Manufacturer Programs That Cut Tirzepatide Cost

Eli Lilly operates three separate savings programs, each of which is aimed at a particular insurance scenario. They do not have any bearing on compounded tirzepatide.

Zepbound Self-Pay Journey ($299 - $449)

Uninsured patients can obtain single-dose vials from LillyDirect. Prices as of October 2026 are $299 for 2.5 mg, $399 for 5 mg, and $449 for 7.5 to 15 mg dosages if refilling within 45 days. If outside that time frame, your dosages will cost $499 for 7.5 mg and $699 for 10 to 15 mg. Not being within the 45-day window means you will have to pay the higher prices for the refill. Please note that no participating retail pharmacies offer this pricing option.

Mounjaro Self-Pay ($499 Flat)

Mounjaro's LillyDirect service charges a flat fee of $499 monthly at any dose level (LillyDirect, October 2026). There are no tiered pricing and refill window. So for patients who expect to reach 10 mg or 15 mg, this flat fee is more affordable than Zepbound's higher-tier prices. Please refer to monthly cost breakdown for 12-month estimates of expense.

Commercial Insurance Savings Cards ($25)

Patients with commercial insurance are allowed to take advantage of the Lilly savings card, which enables them to reduce their co-pay to a minimum of $25 each month (zepbound.lilly.com, October 2026). There is an annual limit imposed. Patients enrolled in Medicare, Medicaid, or any government-Issued insurance plans are not qualified but can take advantage of the GLP-1 Bridge by paying a co-pay of $50 per month. For more details, see our savings card guide.

What Drives the Cost of Tirzepatide

The difference in prices between the branded and compounded forms of tirzepatide is not coincidental. Three fundamental forces help to explain why the price of the same drug is $129 in one place and $1,112 in another.

Patent Status

Eli Lilly has a number of patents on tirzepatide’s molecule, formulation, and delivery device. Since these patents are still active, there can be no generic versions. The lack of generic competition is the main reason for the brand-name price still being more than $1,000. To find more details regarding the patent timeline and potential generic entry, see our generic tirzepatide outlook.

Compounding Economics

Pharmacies designated as 503A can buy large quantities of active pharmaceutical ingredients and avoid the costs of clinical research, advertising, and distribution that determine the cost of the product from Lilly. However, one drawback of using their services is that they do not have regulatory clearance of their final drug product and the quality of the products depends on every specific operation. Our article compounded vs brand comparison gives a broader idea of their advantages and disadvantages.

Demand Effects

After SURMOUNT research showed results of weight loss of over 20, the demand for the product increased significantly in 2024 and 2025. The shortage of common medicines forced a lot of patients to switch to compounding pharmacies, so boosting the growth of this sector. Lilly started developing production and became famous with self-pay bottles, but compounding pharmacists had already secured pricing for their products under $200. Competitive industry forces maintain the price at this level.